Literature DB >> 9459404

A study of 42 episodes of overwhelming post-splenectomy infection: is current guidance for asplenic individuals being followed?

D J Waghorn1, R T Mayon-White.   

Abstract

Individuals without a spleen have an increased risk of overwhelming post-splenectomy infection (OPSI). Improved awareness in recent years has stimulated increased efforts to prevent OPSI. Published guidelines have described policies for immunization, chemoprophylaxis and other measures considered beneficial to asplenic patients, yet OPSI episodes continue to occur. In an attempt to investigate why serious infections are still being seen, we have conducted a nationally based survey of recent OPSI episodes, using mainly a network of medical microbiologists. Data including clinical background to both splenectomy and OPSI episode, immunization and chemoprophylaxis history have been collated. Forty-two cases of overwhelming infection were reported by June 1996. Patients of all ages were affected with OPSI occurring up to 59 years after splenectomy. A mortality rate of 45% was seen. Pneumococcal infection caused at least 37 of 42 episodes, but only 12 patients had received pneumococcal vaccine. Four cases were possible vaccine failures. Only 22% of individuals had taken any chemoprophylaxis since splenectomy, and only one carried a medical alert card. Much more needs to be done to ensure that asplenic patients are warned of the risks of infection, and given at least pneumococcal vaccine. The role of antibiotics for either continual prophylaxis or as a reserve supply for self-prescription at appropriate times also needs greater discussion. Further work on improving pneumococcal vaccine response together with suitable programmes for revaccination are required. Surveillance should continue until the incidence of OPSI reaches an irreducible minimum.

Entities:  

Mesh:

Year:  1997        PMID: 9459404     DOI: 10.1016/s0163-4453(97)93232-1

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  19 in total

Review 1.  Management before hepatectomy for hepatocellular carcinoma with cirrhosis.

Authors:  Hisashi Nakayama; Tadatoshi Takayama
Journal:  World J Hepatol       Date:  2015-09-18

Review 2.  How I treat autoimmune lymphoproliferative syndrome.

Authors:  V Koneti Rao; João Bosco Oliveira
Journal:  Blood       Date:  2011-09-01       Impact factor: 22.113

3.  [Overwhelming postsplenectomy infection syndrome].

Authors:  C Fuchs; C Scheer; K Schulz; F Dombrowski; S Brückmann; S-O Kuhn
Journal:  Anaesthesist       Date:  2014-02-27       Impact factor: 1.041

4.  Outcomes after splenectomy in children: a 48-year population-based study.

Authors:  Mohammad A Khasawneh; Nicolas Contreras-Peraza; Matthew C Hernandez; Christine Lohse; Donald H Jenkins; Martin D Zielinski
Journal:  Pediatr Surg Int       Date:  2019-02-02       Impact factor: 1.827

5.  A survey of vaccine coverage and antibiotic prophylaxis in splenectomised patients in Scotland.

Authors:  M H Kyaw; E M Holmes; J Chalmers; I G Jones; H Campbell
Journal:  J Clin Pathol       Date:  2002-06       Impact factor: 3.411

6.  Anti-Pneumococcal Vaccine-Induced Cellular Immune Responses in Post-Traumatic Splenectomized Individuals.

Authors:  Djursun Karasartova; Umut Gazi; Ozgur Tosun; Ayse S Gureser; Ibrahim T Sahiner; Mete Dolapci; Aysegul T Ozkan
Journal:  J Clin Immunol       Date:  2017-05-09       Impact factor: 8.317

Review 7.  Idiopathic thrombocytopenic purpura.

Authors:  P H Bolton-Maggs
Journal:  Arch Dis Child       Date:  2000-09       Impact factor: 3.791

8.  Post Splenectomy Outcome in β-Thalassemia.

Authors:  Rashid H Merchant; Ami R Shah; Javed Ahmad; Alka Karnik; Nooralam Rai
Journal:  Indian J Pediatr       Date:  2015-06-23       Impact factor: 1.967

9.  Pneumococcal and influenza immunization in asplenic persons: a retrospective population-based cohort study 1990-2002.

Authors:  Joanne M Langley; Linda Dodds; Deshayne Fell; G Ross Langley
Journal:  BMC Infect Dis       Date:  2010-07-22       Impact factor: 3.090

10.  Splenectomy protects against sepsis lethality and reduces serum HMGB1 levels.

Authors:  Jared M Huston; Haichao Wang; Mahendar Ochani; Kanta Ochani; Mauricio Rosas-Ballina; Margot Gallowitsch-Puerta; Mala Ashok; Lihong Yang; Kevin J Tracey; Huan Yang
Journal:  J Immunol       Date:  2008-09-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.